Dr Reddy’s Q4 PAT up 44 per cent at Rs 434 crore
The revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Changing brand name mandatory when changing drug composition: CDSCO
The drug regulator stated that the practice of changing the key therapeutic ingredients in a drug formulation without changing the…
Shilpa Medicare gets USFDA nod for cancer drug
The company has received US FDA final approval for its ANDA for Docetaxel Injection USP in the strengths of 20 mg/mL, 80 mg/4 mL…
Biocon and Mylan to announce the final overall survival data for Ogivri
Ogivri is the first biosimilar for Herceptin approved by the US Food and Drug Administration (FDA) for all indications including…
Pfizer’s atopic dermatitis treatment meets goals in late-stage study
The drug developed by the firm, Abrocitinib, was found to have significantly improved clearing of the skin in patients as compared…
Scientists in new push to control cancer before curing it
Centre for Cancer Drug Discovery, a new centre being set up will “seek to meet the challenge of cancer evolution head on” by…
Lupin gets 3 observations from USFDA for Aurangabad plant
The USFDA carried out the inspection at the plant from May 6 to May 15
Dr. Reddy’s launches Daptomycin for Injection in US
Daptomycin for Injection is a a therapeutic equivalent generic version of Cubicin for Injection
IDMA organises Marketing and Sales Conference, 2019 in Mumbai
The theme of this year's conference was “Growing Brands to Level Next”
LifeArc and GVK BIO celebrate 10 years of partnership
The longevity of this partnership, and the transformative results of the collaboration, serve as a testament to the capabilities…
Seven Indian pharma companies among the 20 sued by the US
44 US states, 20 drug companies, Teva Pharmaceuticals, Aurobindo Pharma, Lupin Wockhardt, Zydus Pharma, Dr Reddy’s Laboratories,…
CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’
Market looks well set for regional boom as second CPhI Middle East & Africa launches in Dubai: Madhukar Tanna, Chief Executive…
IQVIA launches MedTech dedicated to medical device and diagnostics industry
IQVIA MedTech provides innovative technology, focused solutions and consulting services to meet the industry-specific needs of…
Glenmark Pharmaceuticals receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules
The drug is a generic version of Nexium Delayed-Release Capsules, 20 mg and 40 mg, of AstraZeneca Pharmaceuticals LP
UK MHRA’s approval for Wockhardt’s manufacturing facilities continue
The approval was sanctioned for the company's Bhimpore, Kadaiya plants in Daman
DBT comes up with human body mapping project
The project aims at creating a database network of all tissues in the human body from the available scientific literature
The…
P&G announces first quarter financial results
The company has reported a 17 per cent spike in sales from operations for the first quarter
Strides posts revenues worth Rs 8,389 million in Q4FY19
Board recommends dividend of Rs 3 per equity share of face value of Rs 10
Lupin launches generic seizure drug in US
The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United…
Granules India’s total income for FY’19 up by 35 per cent
The company’s consolidated total income for the fourth quarter of FY’19 was Rs 615 crores -- an increase of 20 per cent from the…